The Past, Present, and Future of CIRT for Cervical Cancer: Implementation of “Immuno-CIRT” considering the radiation-induced anti-tumour immune response"  - PDF Version

Wednesday, 16 November 2022 at 17.00 CET.

Dear  Colleagues, Dear  ENLIGHT members

After a  short break  we are  back with  our regular HITRIplus project seminars   

https://www.hitriplus.eu/ .   

For  our  next  seminar we are very pleased to be  hosting  Dr. Noriyuki Okonogi from the  National Institutes for Quantum Science and Technology / QST Hospital  on Wednesday, 16 November 2022 at  17.00 CET. 

Dr. Noriyuki Okonogi, Ph.D., M.D. is a radiation oncologist with expertise in intensity-modulated radiation therapy (IMRT), brachytherapy and particle therapy. He is chief physician (Radiation Oncologist) for the Department of Charged Particle Therapy Research at the National Institutes for Quantum Science and Technology / QST Hospital, where he leads the Clinical Research Group in pelvic tumour. In addition, he is a research fellow in Radiation Oncology at the Massachusetts General Hospital (Harvard Medical School) and a member of the Japanese Pharmaceuticals and Medical Devices Agency and of the forum for Nuclear Cooperation (Asia). HIs current scientific activity is focused on cervical cancer and pelvic tumour, Carbon-ion radiation therapy ((RT) basic and clinical researches), combination of RT and immunotherapy (clinical research) and radiation-induced cell response in non-irradiated cells. He is the recipient of multiple research funds from the prestigious Japan Society for the Promotion of Science.

Dr Okonoji  will  discuss "The Past, Present, and Future of CIRT for Cervical Cancer: Implementation of “Immuno-CIRT” considering the radiation-induced anti-tumor immune response" 

Further information and registration can be found here:  https://indico.cern.ch/event/1212090/

Kind regards,

HITRIplus Communications Team